DE-114 Ophthalmic Solution

· Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DE-114 Ophthalmic Solution, covering 2014-09-23 to 2014-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis [Phase 3]